Literature DB >> 16632216

Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination.

John F Thompson1, Richard A Scolyer, Roger F Uren.   

Abstract

Surgical strategies for managing patients who have primary cutaneous melanoma have changed dramatically over the past 30 years. More conservative excision margins have been shown to be adequate, and routine complete lymph node dissection (CLND)has been abandoned since the sentinel node (SN) biopsy technique was introduced. Knowledge of a patient's SN status not only provides a reliable guide to prognosis, but also allows CLND to be avoided in 80% to 85% of patients. Recent clinical trial results suggest that SN biopsy, with immediate CLND if an SN is positive,confers a survival advantage in those who have metastatic disease in regional nodes. Minimally invasive and noninvasive methods of SN assessment, such as magnetic resonance spectroscopy, are being evaluated.

Entities:  

Mesh:

Year:  2006        PMID: 16632216     DOI: 10.1016/j.soc.2005.12.007

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  4 in total

Review 1.  Surgery and sentinel lymph node biopsy.

Authors:  Mark B Faries; Donald L Morton
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

2.  University Hospital Waterford: 5-year experience of cutaneous melanoma.

Authors:  R Sehgal; C X Cheung; R Alradadi; D A Healy; R Landers; G T O'Donoghue
Journal:  Ir J Med Sci       Date:  2016-11-21       Impact factor: 1.568

3.  Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light.

Authors:  Deborah W Knapp; Larry G Adams; Alec M Degrand; Jacqueline D Niles; José A Ramos-Vara; Ann B Weil; Michael A O'Donnell; Michael D Lucroy; John V Frangioni
Journal:  Eur Urol       Date:  2007-07-16       Impact factor: 20.096

4.  Frontiers of cancer care in Asia-Pacific region: cancer care in Australia.

Authors:  Es Koh; Vt Do; Mb Barton
Journal:  Biomed Imaging Interv J       Date:  2008-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.